Cinitapride SR
Cinitapride SR — prokinetic. Sustained release. Supplied with CoA, MSDS and batch traceability records. From audited GMP facilities.
About this ingredient
Cinitapride agonises 5-HT4 and antagonises 5-HT2 receptors, increasing oesophageal and gastric motility. Commonly used in gastro-oesophageal reflux and functional dyspepsia.
Formulation note
A low dose combined with sustained release demands high content uniformity across pellets.
- Therapeutic class
- Prokinetic
- Release form
- Sustained release
- Typical dosage forms
- Hard capsules
- Pharmacopoeia grade
- Confirmed at quotation
- Manufacturer
- Audited GMP facility
USPBPEPJPIP
Documentation
Supplied with every batch
The documents below ship with the material, ready for regulatory dossiers and GMP inspection.
- 01
CoA
Certificate of Analysis
- 02
MSDS
Material Safety Data Sheet
- 03
CO
Certificate of Origin
- 04
CQ
Certificate of Quality
- 05
GMP
Manufacturer GMP certificate
- 06
DMF
Drug Master File, where available
Same therapeutic class
Prokinetic
Need a quotation or a sample?
Send the ingredient name, grade and expected quantity. Our commercial team responds within one business day.